Story thread · 3 reports / 2 sources

Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market

financialpost.com · 4dShare

AUSTIN, Texas, Sept. 10, 2026 (GLOBE NEWSWIRE) — BioMedWire Editorial Coverage: Today’s multiple sclerosis treatments can slow down disease progression, but none of them halt it outright, and none give back the function patients have already lost. Close to a million people in the United States, and nearly 2.9 million worldwide, live with that reality, […]

First report: A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach — thestar.com, 6d